K-numberK260549
Device nameZSFab Cervical Interbody System and ZSFab Lumbar Interbody System
ApplicantZsfab, Inc.
Product codeODP
Device classClass II
Decision dateApr 24, 2026
DecisionSubstantially Equivalent
Regulation888.3080
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The ZSFab Cervical and Lumbar Interbody Systems are additively manufactured (3D-printed) titanium alloy fusion devices designed to stabilize the spine and facilitate bone fusion. The cervical system treats disc degeneration and spinal instability in the neck (C2–T1) in skeletally mature patients after six weeks of conservative treatment, while the lumbar system addresses degenerative disc disease in the lower spine (L2–S1) after six months of conservative treatment. Both devices feature lattice structures and bone graft windows and are used with supplemental fixation and bone graft material.

Technological characteristics

The subject and predicate devices have identical technological characteristics including indications for use, structure and function, materials of manufacture (titanium alloy Ti-6Al-4V ELI per ASTM F3001), manufacturing process, biocompatibility, sterility, and available sizes. Both cervical and lumbar implants incorporate lattice structures with specified pore dimensions and endplates with teeth design, with no meaningful differences between subject and predicate devices.

Test standards cited

ASTM F2077 dynamic axial compression, ASTM F2077 dynamic compression shear, and ASTM F2077 dynamic torsion testing were performed. The devices are manufactured per ASTM F3001 for titanium alloy specifications. Quality Management System Regulation (QMSR, 21 CFR Part 820) and ISO 13485 standards apply to manufacturing and design controls.

Substantial equivalence argument

The subject devices are substantially equivalent because they have identical technological characteristics to the predicate devices (K242734 and K252610), including indications for use, structure, function, and materials. The submission represents an expansion of production to an additional 3D printer model, with mechanical performance data from ASTM F2077 testing confirming the subject devices perform equivalently to previously cleared devices without raising safety or efficacy concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →